OBJECTIVES: We examined correlations between survival and race/ethnicity, age, and gender among persons who died from AIDS-related causes. METHODS: We estimated survival among 11 022 persons at 12, 36, and 60 months after diagnosis with AIDS in 1993 through 2001 and reported through 2003 to the Chicago Department of Public Health. We estimated hazard ratios (HRs) by demographic and risk characteristics. RESULTS: All demographic groups had higher 5-year survival rates after the introduction of highly active retroviral therapy (1996-2001) than before (1993-1995). The HR for non-Hispanic Blacks to Whites was 1.18 in 1993 to 1995 and 1.51 (P < .01) in 1996 to 2001. The HR for persons 50 years or older to those younger than 30 years was 1.63 in 1993-1995 and 2.28 (P < .01) in 1996-2001. The female-to-male HR was 0.90 in 1993-1995 and 1.20 (P < .02) in 1996-2001. CONCLUSIONS: The risk of death was higher for non-Hispanic Blacks and Hispanics than for non-Hispanic Whites. Interventions are needed to increase early access to care for disadvantaged groups.
OBJECTIVES: We examined correlations between survival and race/ethnicity, age, and gender among persons who died from AIDS-related causes. METHODS: We estimated survival among 11 022 persons at 12, 36, and 60 months after diagnosis with AIDS in 1993 through 2001 and reported through 2003 to the Chicago Department of Public Health. We estimated hazard ratios (HRs) by demographic and risk characteristics. RESULTS: All demographic groups had higher 5-year survival rates after the introduction of highly active retroviral therapy (1996-2001) than before (1993-1995). The HR for non-Hispanic Blacks to Whites was 1.18 in 1993 to 1995 and 1.51 (P < .01) in 1996 to 2001. The HR for persons 50 years or older to those younger than 30 years was 1.63 in 1993-1995 and 2.28 (P < .01) in 1996-2001. The female-to-male HR was 0.90 in 1993-1995 and 1.20 (P < .02) in 1996-2001. CONCLUSIONS: The risk of death was higher for non-Hispanic Blacks and Hispanics than for non-Hispanic Whites. Interventions are needed to increase early access to care for disadvantaged groups.
Authors: Gerald N DeLorenze; Constance Weisner; Ai-Lin Tsai; Derek D Satre; Charles P Quesenberry Journal: Alcohol Clin Exp Res Date: 2010-11-08 Impact factor: 3.455
Authors: Xiuhong Li; Joseph B Margolick; Beth D Jamieson; Charles R Rinaldo; John P Phair; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2011-08-15 Impact factor: 3.731
Authors: Mary Catherine Beach; Somnath Saha; P Todd Korthuis; Victoria Sharp; Jonathon Cohn; Ira Wilson; Susan Eggly; Lisa A Cooper; Debra Roter; Andrea Sankar; Richard Moore Journal: J Gen Intern Med Date: 2010-03-18 Impact factor: 5.128
Authors: Gerald N DeLorenze; Derek D Satre; Charles P Quesenberry; Ai-Lin Tsai; Constance M Weisner Journal: AIDS Patient Care STDS Date: 2010-10-23 Impact factor: 5.078
Authors: Amie L Meditz; Samantha MaWhinney; Amanda Allshouse; William Feser; Martin Markowitz; Susan Little; Richard Hecht; Eric S Daar; Ann C Collier; Joseph Margolick; J Michael Kilby; Jean-Pierre Routy; Brian Conway; John Kaldor; Jay Levy; Robert Schooley; David A Cooper; Marcus Altfeld; Douglas Richman; Elizabeth Connick Journal: J Infect Dis Date: 2011-01-18 Impact factor: 5.226
Authors: M Barton Laws; Yoojin Lee; William H Rogers; Mary Catherine Beach; Somnath Saha; P Todd Korthuis; Victoria Sharp; Jonathan Cohn; Richard Moore; Ira B Wilson Journal: AIDS Behav Date: 2014-07
Authors: Stephanie Konrad; Stuart Skinner; Germain Bukassa Kazadi; Kali Gartner; Hyun June Lim Journal: Can J Infect Dis Med Microbiol Date: 2013 Impact factor: 2.471
Authors: Jeremy D Young; Mahesh Patel; Melissa Badowski; Mary Ellen Mackesy-Amiti; Pyrai Vaughn; Louis Shicker; Michael Puisis; Lawrence J Ouellet Journal: Clin Infect Dis Date: 2014-04-09 Impact factor: 9.079
Authors: Somnath Saha; P Todd Korthuis; Jonathan A Cohn; Victoria L Sharp; Richard D Moore; Mary Catherine Beach Journal: J Gen Intern Med Date: 2013-01-10 Impact factor: 5.128